FUKUSHIMA MEDICAL UNIVERSITY
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Private
- Established
- 1950-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.fmu.ac.jp
Awareness and Knowledge of the Surgical Safety Checklist Among Operational Staff in University Teaching Hospital, Kathmandu, Nepal: A Cross-sectional Questionnaire
Completed
- Conditions
- First Posted Date
- 2019-10-15
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- Fukushima Medical University
- Target Recruit Count
- 150
- Registration Number
- NCT04126889
- Locations
- π³π΅
Tribhuvan University Teaching Hospital, Kathmandu, Nepal
Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT)
- First Posted Date
- 2018-03-05
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- Fukushima Medical University
- Target Recruit Count
- 41
- Registration Number
- NCT03453164
- Locations
- π―π΅
Fukushima Medical University Hospital, Fukushima, Japan
Retinal Sensitivity in BRVO After Anti-VEGF Therapy
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2015-08-19
- Last Posted Date
- 2015-08-19
- Lead Sponsor
- Fukushima Medical University
- Target Recruit Count
- 50
- Registration Number
- NCT02527733
- Locations
- π―π΅
Department of Ophthalmology, Fukushima Medical University, Fukushima, Japan
HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)
- First Posted Date
- 2010-12-24
- Last Posted Date
- 2010-12-24
- Lead Sponsor
- Fukushima Medical University
- Target Recruit Count
- 6
- Registration Number
- NCT01266720
- Locations
- π―π΅
Fukushima Medical University Hospital, Fukushima, Japan
Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma
- First Posted Date
- 2010-12-24
- Last Posted Date
- 2010-12-24
- Lead Sponsor
- Fukushima Medical University
- Target Recruit Count
- 9
- Registration Number
- NCT01266707
- Locations
- π―π΅
Fukushima Medical University Hospital, Fukushima, Japan
Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-04-02
- Last Posted Date
- 2013-08-15
- Lead Sponsor
- Fukushima Medical University
- Target Recruit Count
- 6
- Registration Number
- NCT00874588
- Locations
- π―π΅
Fukushima Medical University, Fukushima, Japan
Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2011-09-08
- Lead Sponsor
- Fukushima Medical University
- Target Recruit Count
- 20
- Registration Number
- NCT00795977
- Locations
- π―π΅
Fukushima Medical University Hospital, Fukushima, Japan
Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-10
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- Fukushima Medical University
- Target Recruit Count
- 17
- Registration Number
- NCT00655785
- Locations
- π―π΅
Fukushima Medical University Hospital, Fukushima, Japan
Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer
- First Posted Date
- 2008-03-20
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- Fukushima Medical University
- Target Recruit Count
- 5
- Registration Number
- NCT00639925
- Locations
- π―π΅
Fukushima Medical University Hospital, Fukushima, Japan
Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-03-12
- Last Posted Date
- 2013-08-15
- Lead Sponsor
- Fukushima Medical University
- Target Recruit Count
- 9
- Registration Number
- NCT00633724
- Locations
- π―π΅
Fukushima Medical University Hospital, Fukushima, Fuskushima, Japan
Β© Copyright 2024. All Rights Reserved by MedPath